Dr. Shontelle Dodson is the vice president of Medical Excellence within Medical Affairs, Global, at Astellas Pharma, Inc., and has extensive clinical and research experience in the healthcare and pharmaceutical industries.
After several years of service in direct patient care at the Department of Veterans Affairs, Shontelle spent 11 years at Pfizer, Inc. in various leadership roles including the US Viagra Medical Team Leader and Senior Director, Group Leader supporting the Urology and Respiratory franchise. Following her work with Pfizer, Shontelle served as Vice President, Medical Affairs at GTx, Inc. In this capacity, she led the Phase 3 clinical development of a selective androgen receptor modulator for the prevention and treatment of muscle wasting in patients with cancer including key economic and health outcomes assessments to support product utilization and valuation. Under her leadership at Astellas, the health outcomes group has pioneered multiple, innovative real world data projects including two national registries in prostate cancer and overactive bladder, as well as partnered research with leading managed care and academic organizations.
She has received multiple awards for leadership and innovation during her career, including the National Healthcare Business Women’s Association Rising Star.
Dr. Dodson holds a Doctor of Pharmacy degree from Mercer University School of Pharmacy and completed a postdoctoral residency at the Department of Veterans Affairs Medical Center in Nashville, Tennessee.